Forum: Insurers' restriction of patient choice undermines trust in system
A s both an obstetrician and gynaecologist in private practice, and a paying health insurance policyholder, I am deeply concerned by the growing trend among insurers to restrict patient choice, first by limiting access to their preferred panels of doctors, and now, increasingly, to selected hospitals as well.
Increasingly, and often led by market leaders, the industry is shifting towards narrower hospital and doctor panels, citing cost containment as justification.
However, these measures appear to be geared towards protecting company profits rather than easing the financial burden on consumers.
While policyholders are being told to accept fewer options for care, insurers continue to report strong financial performance, with some even awarding record bonuses to senior executives.
If the goal is to manage rising healthcare costs, why are the savings not reflected in better coverage or more affordable premiums?
Patients often discover these restrictions only at the point of crisis – when they are ill or in urgent need of care.
This forces difficult and often distressing decisions, especially for those unable to afford out-of-pocket alternatives.
As a doctor, I find it increasingly troubling from an ethical standpoint to practise in a system where clinical decisions are constrained by corporate arrangements.
As a consumer, I feel betrayed – paying more each year for less flexibility, less transparency, and less peace of mind.
These changes undermine trust in the healthcare system and create inequality in access.
I urge the authorities to scrutinise these practices more closely.
Access to appropriate, timely care should never be compromised by commercial interests.
Dr Tan Eng Loy
More on this Topic Forum: What readers are saying
Join ST's Telegram channel and get the latest breaking news delivered to you.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Straits Times
an hour ago
- Straits Times
Brazil declares itself bird flu ‘free', aims to resume exports
The declaration came after Brazil observed a 28-day period without any new commercial farm outbreaks. PHOTO: REUTERS SAO PAULO - The world's largest poultry exporter has declared itself free of the bird flu virus on commercial flocks after observing a 28-day period without any new commercial farm outbreaks, the Brazilian ministry of agriculture said on June 18. The countdown for reclaiming the country's disease-free status began on May 22 following the complete disinfection of the farm where Brazil's only commercial outbreak was detected last month, in the state of Rio Grande do Sul. Under existing trade protocols, China and other importers banned chicken imports from Brazil, which accounts for 39 per cent of global chicken trade, pending measures to control the disease and prevent entrance on other commercial chicken facilities. Now, Brazil aims at resuming chicken exports with its trade partners, but that will require talks with each one of them, Agriculture Minister Carlos Favaro said in a statement. Earlier, a Rio Grande do Sul state official had said Brazil had taken all the steps under health protocols to once again declare itself a free of highly pathogenic avian influenza (HPAI) virus. Reclaiming Brazil's status as free HPAI is not automatic and must be confirmed by the World Organisation for Animal Health, according to guidelines from the body. Brazil's first outbreak hit a chicken breeder farm in the town of Montenegro, where 17,000 birds were culled. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Straits Times
2 hours ago
- Straits Times
Britain's Princess Kate, in recovery from cancer, to miss Royal Ascot race meeting
Britain's Catherine, Princess of Wales, has gradually been returning to her royal duties after completing a course of preventative chemotherapy in 2024. PHOTO: REUTERS Britain's Princess Kate, in recovery from cancer, to miss Royal Ascot race meeting LONDON - Kate, Britain's Princess of Wales, will not be at Royal Ascot on June 18, with a royal source citing her need for balance as she returns to public engagements after being treated for cancer in 2024. Her husband, Prince William, heir to the throne, is set to be part of the royal procession at the horseracing event in southern England later on June 18, alongside his father King Charles and Queen Camilla. The royal source said Kate was disappointed not to be attending. The princess has gradually been returning to her public royal role after completing a course of preventative chemotherapy in 2024 to address the presence of an unspecified form of cancer. Royal Ascot sees top horses from around the world compete over five days in races worth up to a million pounds. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.

Straits Times
5 hours ago
- Straits Times
Forum: Insurers' restriction of patient choice undermines trust in system
A s both an obstetrician and gynaecologist in private practice, and a paying health insurance policyholder, I am deeply concerned by the growing trend among insurers to restrict patient choice, first by limiting access to their preferred panels of doctors, and now, increasingly, to selected hospitals as well. Increasingly, and often led by market leaders, the industry is shifting towards narrower hospital and doctor panels, citing cost containment as justification. However, these measures appear to be geared towards protecting company profits rather than easing the financial burden on consumers. While policyholders are being told to accept fewer options for care, insurers continue to report strong financial performance, with some even awarding record bonuses to senior executives. If the goal is to manage rising healthcare costs, why are the savings not reflected in better coverage or more affordable premiums? Patients often discover these restrictions only at the point of crisis – when they are ill or in urgent need of care. This forces difficult and often distressing decisions, especially for those unable to afford out-of-pocket alternatives. As a doctor, I find it increasingly troubling from an ethical standpoint to practise in a system where clinical decisions are constrained by corporate arrangements. As a consumer, I feel betrayed – paying more each year for less flexibility, less transparency, and less peace of mind. These changes undermine trust in the healthcare system and create inequality in access. I urge the authorities to scrutinise these practices more closely. Access to appropriate, timely care should never be compromised by commercial interests. Dr Tan Eng Loy More on this Topic Forum: What readers are saying Join ST's Telegram channel and get the latest breaking news delivered to you.